JAMA network open , 8 (1), e2457349
Key results: 15 mg dose: Average weight loss of 22.5 percent (approximately 52 pounds for a 230-pound individual) 10 mg dose: Average weight loss of 21.4 percent 5 mg dose: Average weight loss of 16.0 percent Over 85 percent of participants at 10 mg or 15 mg lost at least 10 percent of body weight Over 50 percent at 15 mg lost at least 20 percent SURMOUNT-5, a head-to-head trial comparing tirzepatide to semaglutide, confirmed tirzepatides superiority at matched doses
Both medications can cause nausea, vomiting, diarrhea, indigestion, stomach pain, and constipation
16 Endometriosis Endometriosis is the presence of endometrial tissue outside of the uterine cavity in any region of the pelvis or abdomen
It may be a sign that you need a different dose to maximize results while also avoiding side effects
This is where bioavailability becomes the most important part of the conversation